Genoptræning Danmark ApS: Financial statements 2023
CVR: 41626798
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Genoptræning Danmark ApS (CVR 41626798) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,624,134 and a net result of DKK 114,738 compared with DKK -364,661 the year before. That is an increase of 222.7% compared with the year before. Equity in the 2023 report amounted to DKK -1,491,223. The company had 3 employees in the financial year.
- Gross Profit
- DKK 1,624,134
- Profit/Loss
- DKK 114,738
- Equity
- DKK -1,491,223
- Total Assets
- DKK 1,508,587
- Employees
- 3
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Genoptræning Danmark ApS has published its annual report for 2022. Gross profit came to DKK 503,296, and the net result was DKK -364,661.
About Genoptræning Danmark ApS
Genoptræning Danmark ApS is a Danish company of the type Anpartsselskab based in Aalborg SV, founded in 2020. The company is registered under the industry Andre sociale støtte- og rådgivningsaktiviteter uden institutionsophold. The management consists of Mikkel Salling Holmgaard. The company is owned by Back To Life Holding ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 1,686,355 and a net result of DKK -266,841 compared with DKK 617,783 the year before. Equity in the 2025 report amounted to DKK 109,719.